The Connect Science Seminars seek to connect basic and translational cancer researchers in Houston, Texas, and the nation during the COVID-19 pandemic. The initiative showcases remote seminars by outstanding scientists at major institutions in the U.S. and elsewhere and is open to all.
The series will begin on May 14 and will be held every Thursday at 11 a.m. CST.
For questions or more information, please contact LTAbrahams@mdanderson.org.
Event Sponsors:
- MD Anderson's Department of Cancer Biology
- R.E. "Bob" and Vivian L. Smith Educational Program
- Albert and Margaret Alkek Foundation
Recurrence: Thursdays at 11 a.m. CST
Virtual Platform: Zoom
- Click here to join meeting
- Webinar ID: 948 0526 8120
- Passcode: 599269
Audio (U.S. toll free): 877-853-5257
Webinar ID: 948 0526 8120 | Passcode: 599269
International numbers available: https://mdacc.zoom.us/u/acuwA9MWvn
Audience: Internal and external colleagues from around the world
Organized by
Filippo G. Giancotti, M.D., Ph.D.
Olla S. Stribling Distinguished Chair in Cancer Research
Professor, Department of Cancer Biology
Raghu Kalluri, M.D., Ph.D.
R.E. Bob Smith Distinguished Chair in Cancer Research
Professor and Chair, Department of Cancer Biology
Upcoming Lectures
To facilitate exchange and dissemination of unpublished results, seminars will not be recorded.
May 14
"Stem Cells: Coping with Stress"
Elaine Fuchs, Ph.D.
Rebecca C. Lancefield Professor of Mammalian Cell Biology and Development
Investigator, Howard Hughes Medical Institute
The Rockefeller University
May 21
"New Signal Transduction Targets for Cancer Therapy"
Tony Hunter, Ph.D.
Professor and Renato Dulbecco Chair in Cancer Research
Salk Institute for Biological Studies
May 28
"Of Mice and Men: Learning About Human Prostate Cancer by Studying Mouse Models"
Cory Abate-Shen, Ph.D.
Chair, Department of Pharmacology
Vagelos College of Physicians and Surgeons
Columbia University
June 4
"TBD"
Frederic Geissmann, M.D., Ph.D.
William E. Snee Chair of Immunology
Sloan Kettering Institute
Memorial Sloan Kettering Cancer Center
June 11
"Linking Cancer Metabolism to Neurodegeneration"
Navdeep S. Chandel, Ph.D.
David W. Cugell Professor of Medicine, Biochemistry and Molecular Genetics
Feinberg School of Medicine at Northwestern University
Northwestern University
June 18
"Innate Immune Defense Against Bacterial Pathogens by Inflammasomes"
Russell Vance, Ph.D.
Professor and HHMI Investigator
University of California,
Berkeley
June 25
"Intrinsic and Extrinsic Mechanisms of Hematopoietic
Stem Cell Aging"
Emmanuelle Passegué, Ph.D.
Alumni Professor of Genetics & Development
Director, Columbia Stem Cell Initiative
Columbia University
Irving Medical Center
July 2
"Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer"
Kornelia Polyak, M.D., Ph.D.
Professor of Medicine, Harvard Medical School
Dana-Farber Cancer Institute
July 9
"From Atlases to Programs as Roadmaps to Cancer"
Aviv Regev, Ph.D.
Chair of Faculty and Core Member
Broad Institute of MIT and Harvard
Sept. 10
"Extracellular Matrix: a Key Player in the Tumor Microenvironment"
Richard O. Hynes, Ph.D.
Daniel K. Ludwig Professor for Cancer Research
Koch Institute for Integrative Cancer Research
Department of Biology
Massachusetts Institute of Technology
Sept. 17
"Stem Cell Signals in Cancer Progression and Therapy Resistance"
Tannishtha Reya, Ph.D.
Professor
Pharmacology and Medicine
University of California, San Diego
Sept. 24
"Harnessing Protease Dysregulation to Improve Disease Detection and Monitoring"
Sangeeta N. Bhatia, M.D., Ph.D.
John J. and Dorothy Wilson Professor, Massachusetts Institute of Technology
Director, Marble Center for Cancer Nanomedicine
Investigator, Howard Hughes Medical Institute
Oct. 1
"Genetic Studies to Gain Insight into Neurodegenerative Disorders"
Huda Y. Zoghbi, M.D.
Howard Hughes Medical Institute
Baylor College of Medicine
Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital
Oct. 8
"Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2"
A. Thomas Look, M.D.
Department of Pediatric Oncology
Dana-Farber Cancer Institute
Professor of Pediatrics
Harvard Medical School
Oct. 22
"Intra- and Inter-tumoral Heterogeneity in Small Cell Lung Cancer"
Julien Sage, Ph.D.
Professor of Pediatrics and Genetics
Co-Director of Cancer Biology PhD program
Elaine and John Chambers Professor in Pediatric Cancer
Stanford University
Oct. 29
"TBD"
Robert Schreiber, Ph.D.
AM Bursky & JM Bursky Distinguished Professor
Departments of Pathology & Immunology
Director, Center for Human Immunology and Immunotherapy Programs
Washington University School of Medicine
Nov. 5
“Principles of Organ Regeneration Captured by Live Imaging”
Valentina Greco, Ph.D.
Carolyn Walch Slayman Professor of Genetics
Yale University School of Medicine
Nov. 12
“Overcoming Natural Barriers to Tumorigenesis in Pancreas
Cancer”
Scott Lowe, Ph.D.
Investigator, Howard
Hughes Medical Institute
Chair, Cancer Biology & Genetics
Program, Memorial Sloan Kettering Cancer Center
Chair,
Geoffrey Beene Cancer Research Center, Memorial Sloan Kettering
Cancer Center
Nov. 19
"TBD"
Clodagh O'Shea, Ph.D.
Wicklow Capital Endowed Chair
Howard Hughes Medical Institute Faculty Scholar
Professor, Molecular and Cell Biology Laboratory
Director Redesigning Biology and Medicine Initiative
Salk Institute for Biological Studies
Dec. 3
“Unexpected Functions of The BRCA1 Tumor Suppressing Protein”
David M. Livingston, M.D.
Charles A. Dana Chair in Human Cancer Genetics
Emil Frei III Distinguished Professor of Medicine, Harvard Medical School
Dana-Farber Cancer Institute
Dec. 17
“Deciphering and Targeting Clonal Evolution in Myeloid Malignancies”
Ross L. Levine M.D.
Chief, Molecular Cancer Medicine Service
Human Oncology and Pathogenesis Program
Attending, Leukemia Service, Department of Medicine
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
Jan. 7, 2021
"TBD"
Catherine J. Wu, M.D.
Professor, Medicine, Harvard Medical School
Associate Physician, Medical Oncology, Dana-Farber Cancer Institute
Jan. 14, 2021
"The Makings of B Cell Lymphoma"
Riccardo Dalla-Favera, M.D.
Professor, Pathology & Cell Biology
Professor, Genetics & Development
Professor, Microbiology & Immunology
Director, Institute for Cancer Genetics
Columbia University